Secondary Logo

Journal Logo

Liver Websites

Levitsky, Josh MD, MS; Berenguer, Marina MD

doi: 10.1097/TP.0000000000001359
In View: eResources
Free

1 Division of Gastroenterology & Hepatology Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL.

2 Hepatology and Liver Transplantation Unit, Servicio Medicina Digestivo, La Fe University Hospital, University of Valencia and Ciberehd, Valencia, Spain.

Received March 11, 2016.

Accepted March 14, 2016.

The authors declare no funding or conflicts of interest.

Correspondence: Josh Levitsky, MD, MS, Division of Gastroenterology & Hepatology Northwestern University Feinberg School of Medicine, 676N. St. Clair St., 19th Floor, Chicago, IL 60611. (jlevitsk@nm.org).

A number of existing websites are important resources that collectively provide significant information on clinical and academic aspects for hepatologists and liver disease/transplant providers. Two websites deal with drug-related issues in liver disease. For drug-induced liver toxicity, Livertox [A] has become an extremely helpful resource for daily practice and quickly allows one to check for potential liver toxicity of prescription and over-the-counter drugs as well as many other herbal remedies.

Given the increasing number of drugs prescribed particularly in elderly and transplant recipients, it has become increasingly difficult for clinicians to monitor for potential drug interactions. Hep-drug interactions [B] is an up-to-date and user-friendly website which focuses particularly on drugs which are commonly prescribed by hepatologists and is a very valuable tool in daily practice.

Two major liver societies, the American Association for the Study of Liver Diseases [C] and the European Association for the Study of Liver Diseases [D], have excellent websites providing important information for hepatologists, patients, and providers of liver disease. The American Association for the Study of Liver Diseases periodically summarizes on all relevant liver diseases in straightforward guidelines which make it possible for clinicians to transfer the vast amount of existing literature into evidence-based practice. In much the same way, European Association for the Study of the Liver neatly condenses experimental findings into these guidelines which also provide a European-centered perspective that addresses differences in health care systems and incidence of certain liver diseases.

Link Library

[A] www.livertox.nih.gov.

[B] www.hep-druginteractions.org.

[C] www.aasld.org

[D] www.easl.eu.

[E] www.liverlearning.aasld.org.

[F] http://livertree.easl.eu/easl.

[G] www.clinicaloptions.com/Hepatitis.aspx

[H] www.lillemodel.com.

Associated with both AASLD and EASL, respectively, Liverlearning [E] and Livertree [F] are highly recommended interactive websites for keeping up with the latest advances in hepatology research and broaden knowledge in the field of hepatology.

Clinical care options—Hepatitis [G] is another online resource that provides the latest presentations at national and international meetings regarding hepatitis and liver disease. Finally, Lillemodel [H] provides quick calculations for some of the most frequently used scores in liver disease and severe alcoholic hepatitis, such as MELD, Maddrey, Lille score, ABIC, Glasgow, and others.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.